Fig. 2From: Immune response after SARS-CoV-2 vaccination in patients with inflammatory immune-mediated diseases receiving immunosuppressive treatmentCellular immune response after the second and third vaccine dose. Percentage of patients with a positive or negative cell-mediated immune response after two doses according to treatment. RTX rituximab, TNFi TNF inhibitors, JAKi JAK inhibitorsBack to article page